De Palma, M. & Hanahan, D. Nat. Cancer 5, 827–843 (2024).
Google Scholar
Hudlicka, O., Brown, M. & Egginton, S. Physiol. Rev. 72, 369–417 (1992).
De Palma, M. & Hanahan, D. Nat. Cancer 5, 827–843 (2024).
Google Scholar
Hudlicka, O., Brown, M. & Egginton, S. Physiol. Rev. 72, 369–417 (1992).
A metabolic hub in ciliary and flagellar motion
To investigate differences in the individual cellular architecture of T-ALL during disease progression, we first conducted VASA-seq on initial and relapse-derived…
Following the publication of this article, the authors noted that the KYSE410 USP2 image in Figure 5E was mistakenly duplicated with the KYSE150 shNC image in Figure 5E. Additionally, the KYSE150…
Mirza MR, Coleman RL, González-Martín A, Moore KN, Colombo N, Ray-Coquard I, et al. The forefront of ovarian cancer therapy: update on PARP inhibitors. Ann Oncol. 2020;31:1148–59.
Google…
Lindahl, T. Instability and decay of the primary structure of DNA. Nature 362, 709–715 (1993).
Google Scholar
An, R. et al. Non-enzymatic depurination of nucleic acids:…
Gökbuget, N. et al. Blood 143, 1903–1930 (2024).
Google Scholar
Paietta, E. et al. Blood 138, 948–958 (2021).
…
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This is a summary of: Jiang, C. et al. Innate immunity and the NF-κB pathway control prostate stem cell…
Global RNA sequencing was performed using left ventricular cardiac tissue from HF patients (in comparison to that of healthy controls) to evaluate the…
Arber, D. A. et al. International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data. Blood 140, 1200–1228 (2022).
…